Dr Reddy's Laboratories Ltd has launched Levofloxacin tablets, an antibiotic for treating bacterial infections, in the US market.
“Levofloxacin tablets are the bioequivalent, generic version of Levaquin tablets,” Dr Reddy's said in release.
The tablets in 250 mg and 500 mg strengths are available in 50 count bottles and the 750 mg strength is available in 30 count bottles. The Levaquin brand had US sales of about $1.1 billion for the 12 months ending March 2011, according to IMS Health.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.